TSX Begins Week on Up Note

Home Sales Released

Canada's main stock index rose at the open on Tuesday, led by gains in shares of cannabis company Aphria and miner Wesdome Gold following upbeat quarterly results.

The TSX Composite Index gathered 29.57 points to begin a short week Tuesday at 16,444.73

The Canadian dollar doffed 0.02 cents to 75.57 cents U.S.

Markets in Canada were closed Monday for Thanksgiving.

Aphria shares gained 83 cents, or 13.4%, to $7.04, while Wesdome surged 40 cents, or 6.7%, to $6.34.
Canaccord Genuity started coverage on Knight Therapeutics with a "buy" rating. Knight shares took on a nickel to $7.62.

CIBC cut the target price on Trican Well Service to $1.25 from $1.50. Trican shares docked a penny, or 1.1%, to 94 cents.

On the economic slate, the Canadian Real Estate Association declared national home sales were up slightly in September, rising rose 0.6% month-over-month. Actual (not seasonally adjusted) activity was up 15.5% year-over-year

ON BAYSTREET

The TSX Venture Exchange recouped 3.19 points Tuesday to 543.95

Eight of the 12 Toronto subgroups were positive in the first hour, as health-care sprinted 2.5%, information technology gained 1.5%, and consumer discretionary picked up 0.5%.

The four laggards were weighed most by materials and energy, each down 0.8%, and utilities, reversing 0.5%.

ON WALLSTREET

Stocks traded higher on Tuesday as the corporate earnings season got off to a strong start.

The Dow Jones Industrials soared 148.49 points to begin trading Tuesday at 26,935.85

The S&P 500 improved 18.55 points to 2,984.70.

The NASDAQ Composite leaped 52.94 points, or 1.3%, to 8,101.59

J.P. Morgan Chase shares jumped more than 1.5% after its third-quarter numbers topped analyst expectations. The company’s revenue also hit a record, boosted by home and auto loans along with credit cards.

UnitedHealth, another Dow member, posted a quarterly profit that topped analyst expectations by 13 cents per share. The company’s results got a boost from growing pharmacy benefits. UnitedHealth also hiked its full-year earnings guidance. UnitedHealth shares climbed 6.3%.

Johnson & Johnson, meanwhile, saw its third-quarter numbers lifted by higher sales of cancer and other prescription drugs. The numbers sent the stock up by 2.4%.

So far, 34 S&P 500 components have reported third-quarter numbers. Of those companies, 29 have topped analyst expectations.

Expectations for the corporate earnings season overall were downbeat entering Tuesday. Analysts expect S&P 500 earnings to fall by 4.6% on a year-over-year basis.

United Airlines is among the companies set to report after the bell Tuesday. Netflix, IBM and Bank of America are all scheduled to report Wednesday.

Wall Street also got a boost from stronger-than-forecast economic data. New York’s Empire State manufacturing index hit 4 for October, up from a print of 2 in September. Economists polled by Dow Jones expected a reading of 0.8.

Prices for the benchmark 10-year U.S. Treasury gained a bit of ground in the early going, lowering yields to 1.72% from Friday’s 1.73%. Treasury prices and yields move in opposite directions.

Oil prices shed 39 cents to $53.20 U.S. a barrel.

Gold prices dropped $6.50 to $1,491.10 U.S. an ounce.